Previous 10 | Next 10 |
Rep. Frank Pallone, Jr. (D-N.J.) reintroduced H.R. 3, legislation that would allow the federal government to negotiate prescription drug prices.The bill would cap seniors' out-of-pocket costs on prescription drugs to $2000/year, require drugmakers to issue rebates to the federal government if...
Hot Penny Stocks To Watch Penny stocks are well-known for their higher risk and reward. But a keen understanding of how to trade and invest is key to profiting. Due to their volatility, penny stocks are usually best-known for making big moves quickly. However, at the end of the day,...
This has been a long, long boom in the amount of money that's flowed into this sector, and I don't think I've ever seen anything like it in my own career. This has been VC money going into early-stage startups, it's been IPOs, it's been follow-on financing of already public companies....
Since U.S. Treasury bonds have fallen more than -20% in value, it looks like we might've seen a short-term bottom and an opportunity to profit in the bond market. Which sectors are performing well in the intermediate term, as well as those that are taking a breather in the short term....
One of my many favorite tools to use when analyzing the markets is a Relative Rotation Graph (or “RRG”). I’m going to focus on using RRG to explain what’s happening under the surface in the market today. You can put any benchmark in the middle, at the z...
While the market is hitting all-time highs, shares of the Nasdaq Biotechnology ETF (NASDAQ: IBB) are trading essentially flat year-to-date, down just over 15% from their peak. Down 11% since the beginning of the year, but up just less than fivefold over the past five years , Bluep...
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of thi...
Biotech stocks remain under pressure due to fear of persistently rising interest rates. Neurology is a complex area of biotech with great promise and significant challenges. New approaches are broadening out the innovative paths as the dominant beta amyloid thesis has lost ground....
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. Short review of IDNA. For further details see: Healthcare Dashboard For April And Focus On IDNA
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those ...
News, Short Squeeze, Breakout and More Instantly...
iShares Biotechnology ETF Company Name:
IBB Stock Symbol:
NASDAQ Market:
2024-07-19 00:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 22:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...